Growth Metrics

Exagen (XGN) Gains from Investment Securities (2018 - 2026)

Exagen filings provide 9 years of Gains from Investment Securities readings, the most recent being $100000.0 for Q1 2026.

  • On a quarterly basis, Gains from Investment Securities changed N/A to $100000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $2.6 million, a 762.27% increase, with the full-year FY2025 number at -$792000.0, down 104.65% from a year prior.
  • Gains from Investment Securities hit $100000.0 in Q1 2026 for Exagen, up from -$645000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.7 million in Q3 2025 to a low of -$645000.0 in Q4 2025.
  • Median Gains from Investment Securities over the past 5 years was $100000.0 (2026), compared with a mean of $278000.0.
  • The widest YoY moves for Gains from Investment Securities: up 1346.15% in 2022, down 231.82% in 2022.
  • Exagen's Gains from Investment Securities stood at $641000.0 in 2022, then decreased by 9.98% to $577000.0 in 2023, then tumbled by 167.07% to -$387000.0 in 2024, then crashed by 66.67% to -$645000.0 in 2025, then soared by 115.5% to $100000.0 in 2026.
  • The last three reported values for Gains from Investment Securities were $100000.0 (Q1 2026), -$645000.0 (Q4 2025), and $2.7 million (Q3 2025) per Business Quant data.